Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryn Song

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Clinical Genitourinary Cancer|October 30, 2024
Age Does Not Impact Cancer Specific Mortality: From Sub-Distributional and Cause-Specific Hazard Analysis in RCC Patients Undergoing Radical Nephrectomy and ThrombectomyYounjuong Kim, Jun Gyo Gwon, Hyun Young Lee, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2012
Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk featuresJae-Lyun Lee, Inkeun Park, Kwonoh Park, et al.
Investigative and Clinical Urology|November 8, 2018
Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?Wonchul Lee, Se Young Choi, Chanwoo Lee, et al.
Journal of Cancer|November 16, 2020
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching AnalysisMinyong Kang, Joongwon Choi, Jungyu Kim, et al.
Investigative and Clinical Urology|December 31, 2025
Artificial intelligence-based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: A development and multicenter validationHyun Young Lee, Hwanik Kim, Bumjin Lim, et al.
Chemotherapy|April 4, 2013
Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinomaSeong Joon Park, Jae-Lyun Lee, Inkeun Park, et al.
Clinical Genitourinary Cancer|January 22, 2013
Response evaluation criteria in solid tumors response of the primary lesion in metastatic renal cell carcinomas treated with sunitinib: does the primary lesion have to be regarded as a target lesion?Inkeun Park, Kwonoh Park, Seongjoon Park, et al.
Clinical Genitourinary Cancer|October 24, 2019
Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?Hwiwoo Kim, Sahyun Pak, Kye Jin Park, et al.
Medicine|August 16, 2021
Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium modelDongrul Shin, Chang Wook Jeong, Cheryn Song, et al.
The Journal of Urology|September 28, 2015
Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of ResultsHwang Gyun Jeon, Seong Il Seo, Byong Chang Jeong, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Clinical Genitourinary Cancer|October 30, 2024
Age Does Not Impact Cancer Specific Mortality: From Sub-Distributional and Cause-Specific Hazard Analysis in RCC Patients Undergoing Radical Nephrectomy and ThrombectomyYounjuong Kim, Jun Gyo Gwon, Hyun Young Lee, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2012
Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk featuresJae-Lyun Lee, Inkeun Park, Kwonoh Park, et al.
Investigative and Clinical Urology|November 8, 2018
Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?Wonchul Lee, Se Young Choi, Chanwoo Lee, et al.
Journal of Cancer|November 16, 2020
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching AnalysisMinyong Kang, Joongwon Choi, Jungyu Kim, et al.
Investigative and Clinical Urology|December 31, 2025
Artificial intelligence-based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: A development and multicenter validationHyun Young Lee, Hwanik Kim, Bumjin Lim, et al.
Chemotherapy|April 4, 2013
Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinomaSeong Joon Park, Jae-Lyun Lee, Inkeun Park, et al.
Clinical Genitourinary Cancer|January 22, 2013
Response evaluation criteria in solid tumors response of the primary lesion in metastatic renal cell carcinomas treated with sunitinib: does the primary lesion have to be regarded as a target lesion?Inkeun Park, Kwonoh Park, Seongjoon Park, et al.
Clinical Genitourinary Cancer|October 24, 2019
Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?Hwiwoo Kim, Sahyun Pak, Kye Jin Park, et al.
Medicine|August 16, 2021
Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium modelDongrul Shin, Chang Wook Jeong, Cheryn Song, et al.
The Journal of Urology|September 28, 2015
Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of ResultsHwang Gyun Jeon, Seong Il Seo, Byong Chang Jeong, et al.
Pageof 17